EA202091374A1 - РАСТВОР ДЛЯ ИНЪЕКЦИЙ С pH 7, СОДЕРЖАЩИЙ ПО МЕНЬШЕЙ МЕРЕ ОДИН БАЗАЛЬНЫЙ ИНСУЛИН С pI МЕЖДУ 5,8 И 8,5 И СОПОЛИАМИНОКИСЛОТУ, НЕСУЩУЮ КАРБОКСИЛАТНЫЕ ЗАРЯДЫ И ГИДРОФОБНЫЕ РАДИКАЛЫ - Google Patents
РАСТВОР ДЛЯ ИНЪЕКЦИЙ С pH 7, СОДЕРЖАЩИЙ ПО МЕНЬШЕЙ МЕРЕ ОДИН БАЗАЛЬНЫЙ ИНСУЛИН С pI МЕЖДУ 5,8 И 8,5 И СОПОЛИАМИНОКИСЛОТУ, НЕСУЩУЮ КАРБОКСИЛАТНЫЕ ЗАРЯДЫ И ГИДРОФОБНЫЕ РАДИКАЛЫInfo
- Publication number
- EA202091374A1 EA202091374A1 EA202091374A EA202091374A EA202091374A1 EA 202091374 A1 EA202091374 A1 EA 202091374A1 EA 202091374 A EA202091374 A EA 202091374A EA 202091374 A EA202091374 A EA 202091374A EA 202091374 A1 EA202091374 A1 EA 202091374A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- basal insulin
- injection
- solution
- carried out
- copolyamino acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1855934A FR3083088B1 (fr) | 2018-06-29 | 2018-06-29 | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes |
PCT/EP2018/083896 WO2019110773A1 (fr) | 2017-12-07 | 2018-12-07 | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202091374A1 true EA202091374A1 (ru) | 2020-10-01 |
Family
ID=65031315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202091374A EA202091374A1 (ru) | 2018-06-29 | 2018-12-07 | РАСТВОР ДЛЯ ИНЪЕКЦИЙ С pH 7, СОДЕРЖАЩИЙ ПО МЕНЬШЕЙ МЕРЕ ОДИН БАЗАЛЬНЫЙ ИНСУЛИН С pI МЕЖДУ 5,8 И 8,5 И СОПОЛИАМИНОКИСЛОТУ, НЕСУЩУЮ КАРБОКСИЛАТНЫЕ ЗАРЯДЫ И ГИДРОФОБНЫЕ РАДИКАЛЫ |
Country Status (2)
Country | Link |
---|---|
EA (1) | EA202091374A1 (fr) |
FR (1) | FR3083088B1 (fr) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3837825A1 (de) | 1988-11-08 | 1990-05-10 | Hoechst Ag | Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
FR2801226B1 (fr) | 1999-11-23 | 2002-01-25 | Flamel Tech Sa | Suspension colloidale de particules submicroniques de vectorisation de principes actifs et son mode de preparation |
SK2432004A3 (sk) | 2001-12-20 | 2005-04-01 | Eli Lilly And Company | Inzulínová zlúčenina s protrahovaným účinkom |
FR2840614B1 (fr) | 2002-06-07 | 2004-08-27 | Flamel Tech Sa | Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques |
AU2004234345A1 (en) | 2003-04-29 | 2004-11-11 | Eli Lilly And Company | Insulin analogs having protracted time action |
FR2855521B1 (fr) * | 2003-05-28 | 2005-08-05 | Flamel Tech Sa | Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques. |
FR2910318B1 (fr) * | 2006-12-20 | 2009-07-03 | Flamel Technologies Sa | Dispersion de polyaminoacides dans une phase lipidique continue. |
EP2741765B9 (fr) | 2011-08-10 | 2016-09-28 | Adocia | Solution injectable d'au moins une insuline basale |
CN104114155B (zh) | 2012-01-09 | 2019-02-15 | 阿道恰公司 | Ph为7并且至少包含pi为5.8至8.5之基础胰岛素和经取代共聚(氨基酸)的可注射溶液 |
FR2985428B1 (fr) * | 2012-01-09 | 2016-05-27 | Adocia | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un polyaminoacide substitue |
FR3001896B1 (fr) | 2013-02-12 | 2015-07-03 | Adocia | Solution injectable a ph 7 comprenant au moins une insuline basale dont le point isolectrique est compris entre 5,8 et 8,5 et un polymere anionique hydrophobise |
FR3001895B1 (fr) | 2013-02-12 | 2015-07-03 | Adocia | Solution injectable a ph7 comprenant au moins une insuline basale dont le point isoelectrique est compris en 5,8 et 8,5 et un compose anionique porteur de charges carboxylates et de radicaux hydrophobes |
-
2018
- 2018-06-29 FR FR1855934A patent/FR3083088B1/fr active Active
- 2018-12-07 EA EA202091374A patent/EA202091374A1/ru unknown
Also Published As
Publication number | Publication date |
---|---|
FR3083088B1 (fr) | 2020-10-02 |
FR3083088A1 (fr) | 2020-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201892737A1 (ru) | ИНЪЕКЦИОННЫЙ РАСТВОР ПРИ pH 7, ВКЛЮЧАЮЩИЙ ПО МЕНЬШЕЙ МЕРЕ ОДИН БАЗАЛЬНЫЙ ИНСУЛИН, pI КОТОРОГО ИМЕЕТ ЗНАЧЕНИЕ ОТ 5,8 ДО 8,5, И СОПОЛИАМИНОКИСЛОТУ, НЕСУЩУЮ КАРБОКСИЛАТНЫЕ ЗАРЯДЫ И ГИДРОФОБНЫЕ РАДИКАЛЫ | |
PH12020550827A1 (en) | Injectable solution at ph 7 comprising at least one basal insulin having a pi of between 5.8 and 8.5 and a copolyamino acid carrying carboxylate charges and hydrophobic radicals | |
SG11201810939PA (en) | Compositions in the form of an injectable aqueous solution, comprising human glucagon and an end-grafted copolyamino acid | |
ECSP19046507A (es) | Dinucleótidos cíclicos como agonistas de sting (estimulador de genes de interferón) | |
PH12020550804A1 (en) | Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a copolyamino acid | |
PH12020550828A1 (en) | Compositions in the form of an injectable aqueous solution comprising human glucagon and a copolyamino acid | |
MX2021009060A (es) | Reduccion del riesgo de infeccion viral por pienso con contaminacion viral. | |
MA49678A (fr) | Compositions sous forme d'une solution aqueuse injectable comprenant au moins l'insuline humaine a21g et un suppresseur de glucagon a action prandiale | |
MA51127A (fr) | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes | |
BR112016007328A2 (pt) | composições oftálmicas baseadas em epinefrina para administração intraocular e métodos para fabricar as mesmas | |
SG11202005322RA (en) | Injectable solution at ph 7 comprising at least one basal insulin having a pi of between 5.8 and 8.5 and a copolyamino acid carrying carboxylate charges and hydrophobic radicals | |
EA201691951A1 (ru) | Дисперсия улучшенной отверждаемой свободной от формальдегида смолы, характеризующаяся уменьшенной вязкостью, и продукты на основе минеральной ваты, полученные при ее использовании | |
EA202091374A1 (ru) | РАСТВОР ДЛЯ ИНЪЕКЦИЙ С pH 7, СОДЕРЖАЩИЙ ПО МЕНЬШЕЙ МЕРЕ ОДИН БАЗАЛЬНЫЙ ИНСУЛИН С pI МЕЖДУ 5,8 И 8,5 И СОПОЛИАМИНОКИСЛОТУ, НЕСУЩУЮ КАРБОКСИЛАТНЫЕ ЗАРЯДЫ И ГИДРОФОБНЫЕ РАДИКАЛЫ | |
MX2020004842A (es) | Compuestos heterociclicos antiinfecciosos y sus usos. | |
FR3074681B1 (fr) | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes | |
EA202091387A1 (ru) | Композиции в форме инъецируемого водного раствора, содержащие человеческий глюкагон и сополиаминокислоту | |
EA202091201A1 (ru) | Композиции в форме инъецируемого водного раствора, содержащие амилин, агонист рецептора амилина или аналог амилина и сополиаминокислоту | |
FR3061023B1 (fr) | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide | |
FR3074422B1 (fr) | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes | |
FR3074682B1 (fr) | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide | |
FR3074680B1 (fr) | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide | |
EA202092577A1 (ru) | Катионный полимер и применение для доставки биомолекул | |
UA125589U (uk) | Композиція для естетичних ін'єкцій | |
UA123185U (uk) | СПОСІБ ОДЕРЖАННЯ СТАБІЛЬНОГО СТЕРИЛЬНОГО РОЗЧИНУ α-ЛІПОЄВОЇ КИСЛОТИ ДЛЯ ПАРЕНТЕРАЛЬНОГО ВВЕДЕННЯ | |
FR3074683B1 (fr) | Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide |